• No results found

Treatment against Mutation of PIK3CA Gene Involved in Lung Cancer by Structure Base Pharmacophore Modeling, Virtual Screening and Molecular Docking

N/A
N/A
Protected

Academic year: 2020

Share "Treatment against Mutation of PIK3CA Gene Involved in Lung Cancer by Structure Base Pharmacophore Modeling, Virtual Screening and Molecular Docking"

Copied!
14
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1.  Method for Designing Pharmacophore Model against PIK3CA mutation in Lung Cancer
Figure 2.  3-D Structure of Proteins along with Ligands
Figure 3.  Pharmacophore and Interactions of 5UKJ
Figure 5.  Pharmacophore and Interactions of 5UK8
+4

References

Related documents

The primary and secondary data presented in this paper show how the national political, socio-economic, telecommu- nication and legal contexts affect the adoption or rejec- tion of

In this paper, ballast material typically employed in rail track bed construction has been characterized. Laboratory tests have been carried out over a methacrylate tank, which

• There must be at least one statement in the body of the loop that affects the value of the boolean expression, otherwise if the condition is true initially then the loop will

In the early clinical reports of posterior hemivertebra resection with transpedicular instrumentation, Ruf and Harms reported 28.5 % of 28 cases with mean age of 3 years and 4

Leadership Performance Culture Employee Relations Pay and Reward Talent Management Learning Organisation LEADERSHIP – PILLAR 1...

93 While the Cable Act of 1992 does not repeal the compulsory license for importation of distant signals, for the first time it gives broadcasters the right to

Table 1 Objective Structured Assessment of Technical Skills assessment test: each trainee was evaluated in five different task with a score from 1 (low) to 5 (high) (Continued) TASK

100 patients with oral squamous cell carcinoma were investigated using molecular and Immunohistochemical detection for PTEN gene, their ages ranging from 33 to 89 years